NEXAF
The Norwegian Exercise in Atrial Fibrillation Trial
In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.
Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms — the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.